Download PDF

Other users also viewed these articles

O-24 PIRFENIDONE PREVENTS NEOPLASTIC LESIONS DEVELOPMENT BY OXIDATIVE, FIBROGENIC, ANTIPROLIFERATIVE AND EPIGENETIC MECHANISMS REGULATION IN A MODEL OF CHEMICAL HEPATOCARCINOGENESIS Hipólito Otoniel Miranda-Roblero; Hugo Christian Monroy-Ramírez; Marina Galicia-Moreno; Ana Sandoval-Rodriguez; Arturo Santos; Juan Armendáriz-Borunda;
Ann Hepatol. 2023;28 Supl 1:
Pirfenidone limits the progression of malignancy and slows the development of fibrosis in experimental hepatocarcinoma. Scarlet Arceo-Orozco; Fernando Caloca-Camarena; Roberto Flores-Peña; Marina Galicia-Moreno; Hugo Christian Monroy-Ramírez; Juan Armendáriz-Borunda;
Ann Hepatol. 2025;30 Supl 1:
Prolonged release pirfenidone restores miRNA expression and CpG island methylation in patients with HCV sustained virological response and residual liver fibrosis Eira Cerda-Reyes; Ricardo de la Rosa-Bibiano; Ana Sandoval-Rodriguez; Rebeca Rosas-Campos; Rebeca Escutia-Gutiérrez; Ángel Vázquez-Esqueda; Stefanny Cornejo-Hernández; Alejandro Gutiérrez-Átemis; Salvador Amezquita-Pérez; Jorge Luis Poo; Gildardo Agustin Garrido-Sanchez; Juan Ramón-Aguilar; Juan Armendáriz-Borunda;
Ann Hepatol. 2025;30 Supl 1: